Case Study

Case Study: Proactive Strategies for Meeting NDA Timelines Despite Last-Minute Supplemental Study Requests

On-time NDA submission success story

Read more

Five last-minute studies were accommodated, executed, analyzed, and properly documented for successful NDA submission to the FDA and EMA in just 8 months. Read the full case study here.


Chief Scientific Officer, Early Phase Development
Senior Vice President, Clinical Operations Early Phase

Want to learn more about Worldwide Clinical Trials?